Industry Conference

Celebrating its 40th anniversary, ITE Hong Kong reinforces its pivotal role, connecting global destinations with the affluent, independent traveler of the GBA.

Retail's next frontier is here. AI agents are moving beyond chatbots to autonomously discover, select, and purchase goods on your behalf. Here's what's coming.

With its revolutionary Prime Editing tech showing promise, Prime Medicine faces a pivotal moment at the J.P. Morgan conference. Can it justify its new strategy?

Azitra will present its novel AI-driven skin therapies for rare diseases at Biotech Showcase, seeking crucial funding and partnerships to advance its pipeline.

With positive Phase 2 results for its antibody AP-101, AL-S Pharma targets a key protein in both genetic and sporadic forms of ALS, offering new hope.

Beauty giant L'Oréal partners with LED innovator iSMART, signaling a new era of professional-grade light therapy devices for your daily routine.

Pricer's successful UK pilot of its battery-free Avenue™ platform confirms a new era of dynamic, revenue-generating shelf-edge experiences is coming.

The Japanese government's 'SUI COLLECTION' is showcasing hidden artisanal treasures to the world, blending tradition with modern luxury in a bold cultural push.

CES 2026 opens with AI dominating everything from PCs to factories, while Las Vegas reaps the rewards of a massive convention center overhaul.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Transcarent's WayFinding 2.0 moves beyond chat, using 'agentic AI' to schedule appointments, create health plans, and actively manage your care.

A new validation milestone between LitePoint and Qualcomm shows Wi-Fi 8 is approaching, promising ultra-reliable networks for AI, AR, and mission-critical IoT.

Amid rising grid complexity and cyber threats, Haivision's real-time video solutions aim to give utility operators unprecedented situational awareness.

Winning Data Platform of the Year, Authenticom’s DXM connects live operations with customer sentiment, aiming to fix problems before they happen.

With a major new facility planned and a dynamic market, all eyes are on Clean Harbors as it prepares to address investors at two key January events.

Bio-Rad's leadership will meet investors at the J.P. Morgan conference, facing questions on strategy and growth in a competitive, tech-driven market.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

From your living room to your car, Dolby's latest CES announcements reveal a strategy to embed immersive entertainment into every aspect of your life.

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

A new antibody-drug conjugate, DEM301, shows preclinical promise by targeting a unique protein to directly kill tumors and unleash the immune system.